Clinical Trial Update: Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immunogenicity and safety of PriorixTetra when co-administered with a conjugated MenC vaccine in healthy children; completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• Conjugated MenC vaccine
• PriorixTetra (measles, mumps, rubella, varicella vaccine (attenuated) - quadrivalent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rubella, Varicella | Phase 3 | Status: COMPLETED | Results posted: 2017-01-09